S

Sophia Genetics SA
NASDAQ:SOPH

Watchlist Manager
Sophia Genetics SA
NASDAQ:SOPH
Watchlist
Price: 3.99 USD 5.28% Market Closed
Market Cap: 260.8m USD
Have any thoughts about
Sophia Genetics SA?
Write Note

Intrinsic Value

SOPH's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one SOPH stock under the Base Case scenario is 4.69 USD. Compared to the current market price of 3.99 USD, Sophia Genetics SA is Undervalued by 15%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

SOPH Intrinsic Value
4.69 USD
Undervaluation 15%
Intrinsic Value
Price
S
Worst Case
Base Case
Best Case

Valuation Backtest
Sophia Genetics SA

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for SOPH cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about SOPH?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Sophia Genetics SA

Provide an overview of the primary business activities
of Sophia Genetics SA.

What unique competitive advantages
does Sophia Genetics SA hold over its rivals?

What risks and challenges
does Sophia Genetics SA face in the near future?

Summarize the latest earnings call
of Sophia Genetics SA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Sophia Genetics SA.

Provide P/S
for Sophia Genetics SA.

Provide P/E
for Sophia Genetics SA.

Provide P/OCF
for Sophia Genetics SA.

Provide P/FCFE
for Sophia Genetics SA.

Provide P/B
for Sophia Genetics SA.

Provide EV/S
for Sophia Genetics SA.

Provide EV/GP
for Sophia Genetics SA.

Provide EV/EBITDA
for Sophia Genetics SA.

Provide EV/EBIT
for Sophia Genetics SA.

Provide EV/OCF
for Sophia Genetics SA.

Provide EV/FCFF
for Sophia Genetics SA.

Provide EV/IC
for Sophia Genetics SA.

Show me price targets
for Sophia Genetics SA made by professional analysts.

What are the Revenue projections
for Sophia Genetics SA?

How accurate were the past Revenue estimates
for Sophia Genetics SA?

What are the Net Income projections
for Sophia Genetics SA?

How accurate were the past Net Income estimates
for Sophia Genetics SA?

What are the EPS projections
for Sophia Genetics SA?

How accurate were the past EPS estimates
for Sophia Genetics SA?

What are the EBIT projections
for Sophia Genetics SA?

How accurate were the past EBIT estimates
for Sophia Genetics SA?

Compare the revenue forecasts
for Sophia Genetics SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Sophia Genetics SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Sophia Genetics SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Sophia Genetics SA compared to its peers.

Compare the P/E ratios
of Sophia Genetics SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Sophia Genetics SA with its peers.

Analyze the financial leverage
of Sophia Genetics SA compared to its main competitors.

Show all profitability ratios
for Sophia Genetics SA.

Provide ROE
for Sophia Genetics SA.

Provide ROA
for Sophia Genetics SA.

Provide ROIC
for Sophia Genetics SA.

Provide ROCE
for Sophia Genetics SA.

Provide Gross Margin
for Sophia Genetics SA.

Provide Operating Margin
for Sophia Genetics SA.

Provide Net Margin
for Sophia Genetics SA.

Provide FCF Margin
for Sophia Genetics SA.

Show all solvency ratios
for Sophia Genetics SA.

Provide D/E Ratio
for Sophia Genetics SA.

Provide D/A Ratio
for Sophia Genetics SA.

Provide Interest Coverage Ratio
for Sophia Genetics SA.

Provide Altman Z-Score Ratio
for Sophia Genetics SA.

Provide Quick Ratio
for Sophia Genetics SA.

Provide Current Ratio
for Sophia Genetics SA.

Provide Cash Ratio
for Sophia Genetics SA.

What is the historical Revenue growth
over the last 5 years for Sophia Genetics SA?

What is the historical Net Income growth
over the last 5 years for Sophia Genetics SA?

What is the current Free Cash Flow
of Sophia Genetics SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Sophia Genetics SA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Sophia Genetics SA

Current Assets 117.2m
Cash & Short-Term Investments 95.8m
Receivables 9.8m
Other Current Assets 11.7m
Non-Current Assets 60.4m
PP&E 21.8m
Intangibles 30.4m
Other Non-Current Assets 8.3m
Current Liabilities 30.9m
Accounts Payable 5.9m
Accrued Liabilities 13.8m
Other Current Liabilities 11.2m
Non-Current Liabilities 33.2m
Long-Term Debt 29.2m
Other Non-Current Liabilities 4m
Efficiency

Earnings Waterfall
Sophia Genetics SA

Revenue
64.5m USD
Cost of Revenue
-20.8m USD
Gross Profit
43.7m USD
Operating Expenses
-111.8m USD
Operating Income
-68.1m USD
Other Expenses
-3.3m USD
Net Income
-71.4m USD

Free Cash Flow Analysis
Sophia Genetics SA

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

SOPH Profitability Score
Profitability Due Diligence

Sophia Genetics SA's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
ROIC is Increasing
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
27/100
Profitability
Score

Sophia Genetics SA's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

SOPH Solvency Score
Solvency Due Diligence

Sophia Genetics SA's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Low D/E
Long-Term Solvency
50/100
Solvency
Score

Sophia Genetics SA's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SOPH Price Targets Summary
Sophia Genetics SA

Wall Street analysts forecast SOPH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SOPH is 6.12 USD with a low forecast of 5.05 USD and a high forecast of 7.35 USD.

Lowest
Price Target
5.05 USD
27% Upside
Average
Price Target
6.12 USD
53% Upside
Highest
Price Target
7.35 USD
84% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for SOPH?

Click here to dive deeper.

Dividends

Sophia Genetics SA
does not pay dividends
Shareholder Yield

Current shareholder yield for SOPH is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Sophia Genetics SA

Country

Switzerland

Industry

Health Care

Market Cap

265.1m USD

Dividend Yield

0%

Description

SOPHiA GENETICS SA is a healthcare technology company, which establishes the practice of data driven medicine as the standard of care and for life sciences research. The firm offer a cloud-based Software-as-a-Service platform - the SOPHiA DDM, which is data-driven medicine platform enabling insights from disparate, complex datasets to improve diagnosis, treatment, and drug development. The firm has offices in Switzerland, France and the United Kingdom and operates worldwide.

Contact

VAUD
Rue du Centre 172, Saint Sulpice
+41216941060.0
www.sophiagenetics.com

IPO

2021-07-23

Employees

518

Officers

Co-Founder, CEO & Director
Dr. Jurgi Camblong M.B.A., Ph.D.
Executive VP, CFO & COO
Mr. Ross Jordan Muken B.Sc.
Senior VP & CTO
Mr. Abhimanyu Verma
Executive VP & Chief Scientific Officer
Dr. Zhenyu Xu Ph.D.
Vice President of Investor Relations
Katherine Bailon
Executive VP, Chief Legal & Compliance Officer
Mr. Daan van Well L.L.M., M.B.A.
Show More
Executive VP & Chief People Officer
Ms. Manuela Da Silva Valente B.A.
VP & MD of EMEA
Mr. Kevin Puylaert
Executive VP, Chief Medical Officer & Chief Product Officer
Dr. Philippe Menu M.B.A., M.D., Ph.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one SOPH stock?

The intrinsic value of one SOPH stock under the Base Case scenario is 4.69 USD.

Is SOPH stock undervalued or overvalued?

Compared to the current market price of 3.99 USD, Sophia Genetics SA is Undervalued by 15%.

Back to Top